These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25539612)

  • 1. Research progress on the relationship between lung cancer drug-resistance and microRNAs.
    Ma X; Liang AL; Liu YJ
    J Cancer; 2019; 10(27):6865-6875. PubMed ID: 31839821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview.
    Tibaldi C; D'Incecco A; Lagana A
    Anticancer Agents Med Chem; 2015; 15(6):694-700. PubMed ID: 25612681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.
    Minguet J; Smith KH; Bramlage P
    Int J Cancer; 2016 Jun; 138(11):2549-61. PubMed ID: 26537995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
    Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
    Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer.
    Qin X; Xu H; Gong W; Deng W
    Front Oncol; 2014; 4():357. PubMed ID: 25601903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy.
    Budi HS; Younus LA; Lafta MH; Parveen S; Mohammad HJ; Al-Qaim ZH; Jawad MA; Parra RMR; Mustafa YF; Alhachami FR; Karampoor S; Mirzaei R
    Front Oncol; 2022; 12():1067974. PubMed ID: 36793341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis.
    Zou Y; Zhong C; Hu Z; Duan S
    Front Oncol; 2021; 11():743701. PubMed ID: 34676171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑128‑b regulates epidermal growth factor receptor expression in non‑small cell lung cancer.
    Li L; Wang D
    Mol Med Rep; 2019 Dec; 20(6):4803-4810. PubMed ID: 31638205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
    Jin S; He J; Li J; Guo R; Shu Y; Liu P
    Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the epidermal growth factor receptor gene and its impact on the efficacy of gefitinib in advanced non-small cell lung cance.
    Li XN; Qiu D; Pan X; Hou XX
    Int J Clin Exp Med; 2015; 8(4):5397-405. PubMed ID: 26131116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
    Zhang K; Yuan Q
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
    Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
    Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.
    Tan CS; Cho BC; Soo RA
    Lung Cancer; 2016 Mar; 93():59-68. PubMed ID: 26898616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advance in microRNAs and EGFR-TKIs secondary resistance research in non-small cell lung cancer].
    Duan X; Shi J
    Zhongguo Fei Ai Za Zhi; 2014 Dec; 17(12):860-4. PubMed ID: 25539612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advanced Research on MicroRNAs and EGFR-TKIs Secondary Resistance].
    Wang M; Sun Z; Huang L
    Zhongguo Fei Ai Za Zhi; 2015 Dec; 18(12):758-63. PubMed ID: 26706953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer.
    Ma P; Zhang M; Nie F; Huang Z; He J; Li W; Han L
    Biomed Pharmacother; 2017 Mar; 87():20-26. PubMed ID: 28040594
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.